Contact | Print version | PDF version | Send article | RSS-Feed

CollPlant developing Type I Recombinant Human Collagen from Transgenic Tobacco Plants

06 May 2008 - CollPlant Ltd., a biotechnology company specializing in the development and commercialization of novel medical products based on its plant-derived, Type I collagen and other recombinant proteins, announced that they elected Mr. Ronny Barak as Chief Executive Officer and Director of CollPlant.
 
Mr. Barak, 40, has been Chief Executive Officer and General Manager of Disc-O-Tech, in Princeton, N.J. USA, since 2005 and prior to that Vice President of Sales & Marketing - Spine. While at Disc-O-Tech, together with the management team, he led the company in signing a successful acquisition transaction with Kyphon/ Medtronic Corp. Prior to Disc-O-Tech, he served as Franchise Development Group Manager- Inter-Continental Division of Boston Scientific and Vice President and Managing Director at A.M.I. Technologies, Ltd in Israel, a medium sized medical device distribution company. He holds a Bachelor of Science degree in Chemistry from the Hebrew University of Jerusalem and a Masters in Business Administration degree specializing in Marketing from The Ramat Gan College in Israel.